EMEA-002854-PIP01-20 - paediatric investigation plan

(1R,2R,3S,4S,5R,6S)-cyclohexane-1,2,3,4,5,6-hexayl-hexakis (dihydrogen phosphate)
PIPHuman

Key facts

Active Substance
(1R,2R,3S,4S,5R,6S)-cyclohexane-1,2,3,4,5,6-hexayl-hexakis (dihydrogen phosphate)
Therapeutic area
Other
Decision number
P/0472/2020
PIP number
EMEA-002854-PIP01-20
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of calciphylaxis
Route(s) of administration
Intravenous use
Contact for public enquiries

Sanifit Therapeutics S.A.

Email: info@sanifit.com    
Tel. +34 971439925
 

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date

Decision

Share this page